Glen Eagle Advisors, LLC

SEC CIK: 0002029317
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

PFE holding history

Pfizer Inc in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overview All 13F holders of PFE Full Q2 2026 holdings

Shares (Q2 2026): 30,849
Value: $742.9K
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of PFE by Glen Eagle Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	30,849	$742.9K	0.1%	+9,196+42.5%	Added	Holders
Q1 2026	21,653	$608.0K	0.1%	−2,406−10.0%	Reduced	Holders
Q4 2025	24,059	$599.1K	0.1%	−7,964−24.9%	Reduced	Holders
Q3 2025	32,023	$816.0K	0.1%	+6,624+26.1%	Added	Holders
Q2 2025	25,399	$615.7K	0.1%	+730+3.0%	Added	Holders
Q1 2025	24,669	$625.1K	0.1%	−5,193−17.4%	Reduced	Holders
Q4 2024	29,862	$792.3K	0.1%	+5,796+24.1%	Added	Holders
Q3 2024	24,066	$696.5K	0.1%	−2,902−10.8%	Reduced	Holders
Q2 2024	26,968	$754.6K	0.1%	−10,979−28.9%	Reduced	Holders
Q1 2024	37,947	$1.05M	0.2%	−5,260−12.2%	Reduced	Holders
Q4 2023	43,207	$1.24M	0.3%	−7,777−15.3%	Reduced	Holders
Q3 2023	50,984	$1.69M	0.4%	−273−0.5%	Reduced	Holders
Q2 2023	51,257	$1.88M	0.4%	+5,198+11.3%	Added	Holders
Q1 2023	46,059	$1.88M	0.5%	+2,547+5.9%	Added	Holders
Q4 2022	43,512	$2.23M	0.6%	−441−1.0%	Reduced	Holders
Q3 2022	43,953	$1.92M	0.6%	−8,634−16.4%	Reduced	Holders
Q2 2022	52,587	$2.76M	0.7%	+5,514+11.7%	Added	Holders
Q1 2022	47,073	$2.44M	0.6%	−99−0.2%	Reduced	Holders
Q4 2021	47,172	$2.79M	0.7%	−1,641−3.4%	Reduced	Holders
Q3 2021	48,813	$2.10M	0.6%	+2,736+5.9%	Added	Holders
Q2 2021	46,077	$1.80M	0.6%	+1,080+2.4%	Added	Holders
Q1 2021	44,997	$1.64M	0.6%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.